Boots, the UK retailer which has put its healthcare business up for sale, announced today that it has appointed UBS as a joint corporate broker.

Boots, with a market capitalisation of £4.7bn (€6.9bn), appointed the Swiss bank alongside Merrill Lynch, which kept its mandate despite losing a team of brokers, led by Paul Baker, to Morgan Stanley last year.